![]() |
市場調查報告書
商品編碼
2026741
安全針市場預測至2034年-按產品、應用、最終用戶和地區分類的全球分析Safety Needles Market Forecasts to 2034 - Global Analysis By Product, Application, End User and By Geography |
||||||
根據 Stratistics MRC 的數據,預計到 2026 年,全球安全針市場規模將達到 24 億美元,並在預測期內以 9.3% 的複合年成長率成長,到 2034 年將達到 50 億美元。
內建安全功能的醫用針頭稱為安全針。這些產品旨在透過降低接觸血液傳播病原體的風險來提高患者的整體安全,從而保護患者和醫護人員免受針刺傷等意外傷害。此外,各種類型和尺寸的安全針頭可用於診所、醫院和其他醫療機構的各種醫療操作中,提供全方位的防護。
據世界衛生組織稱,由於疫情爆發後政府支出暫時增加,2020年全球醫療保健支出飆升至近9兆美元。
患者賦權
患者賦權是指患者積極參與自身醫療保健決策,包括選擇更安全的醫療設備,例如安全針頭,這是推動安全針頭市場成長的主要因素。患者優先考慮舒適性和安全性,因此往往更傾向於選擇精準度高、不適感小、針刺傷風險低的安全針頭。此外,充分了解情況並擁有自主權的患者群體對市場的需求,也促使醫療服務提供者採用能夠滿足患者對更安全、更有效的醫療保健體驗需求的安全針頭解決方案。
前期成本高
這些產品的初始成本可能會成為醫療專業人員投資的障礙。此外,由於安全針頭具有增強的安全功能,其價格通常高於標準針頭。儘管安全針頭有助於減少針刺傷並提高整體醫療安全,但短期財務限制可能會阻礙其廣泛應用。然而,與標準針頭相比,這些安全功能的增加會增加製造成本。因此,這可能會減緩市場滲透速度,並限制人們獲得更安全的針頭。
針頭安全性的技術進步
與智慧型設備和電子健康記錄的整合等創新功能增強了追蹤、管理和合規性。降低針刺傷風險的針頭安全技術提高了病患和醫護人員的信心。這為減輕職場風險提供了切實可行的解決方案,並促進了更安全的醫療實踐。此外,人們對血液傳播病原體相關風險的認知不斷提高,促使安全功能得到改進,而監管要求也加速了這些功能的應用,從而推動了市場成長。
缺乏意識
醫療機構和醫護人員往往不了解安全針頭的可用性和益處,這給安全針頭市場帶來了挑戰。由於醫護人員可能繼續使用普通針頭而忽略風險,這可能導致安全針頭的使用率下降。此外,缺乏關於安全針頭益處和正確使用方法的教育和培訓也是阻礙市場擴張的另一個因素。
新冠疫情的感染疾病
新冠疫情對安全針市場造成了衝擊。由於擇期手術和非緊急治療的取消或推遲,對安全針的需求有所下降。此外,全球供應鏈和生產流程的中斷進一步阻礙了這些產品的生產和分銷。同時,由於醫療機構將重點放在控制疫情和應對後續工作上,對安全針和其他醫療用品的關注和資金投入有所減少,這反過來又抑制了市場成長。
在預測期內,靜脈輸液導管針段預計將是尺寸最大的部分。
靜脈輸液針頭預計將佔據最大的市場佔有率,這主要得益於靜脈輸液治療需求的成長以及對減少針刺傷的日益重視。為了降低靜脈輸液導管插入和拔除過程中意外穿刺的風險,針頭鎖定裝置、人性化操作技術和舒適性設計等技術進步被廣泛應用。此外,伸縮式或防護裝置也常用於保護病患和醫護人員,進一步推動了該細分市場的成長。
在預測期內,藥物傳輸領域預計將呈現最高的複合年成長率。
在預測期內,藥物傳輸領域預計將呈現最高的複合年成長率。此細分市場的創新,例如採用內建安全功能的注射器和針頭的藥物輸送系統,使藥物注射更加安全便捷。這些進步對於需要自我給藥的疾病(例如糖尿病和自體免疫疾病)尤其重要。此外,隨著病患舒適度和安全標準的提高以及醫療保健需求的演變,醫護人員和病患都更加重視更安全、更有效率的藥物輸送方式,這推動了該細分市場的成長。
在預測期內,歐洲佔據了最大的市場佔有率,這主要得益於為提高工人安全、減少針刺傷和預防血液傳播疾病而實施的法規和獎勵。該地區擁有強生、柯惠醫療、貝克頓·迪金森公司和史密斯醫療等領先企業,這些企業致力於產品創新和技術進步,以滿足不斷變化的安全標準。此外,安全針頭產品的推出也得到了財政支持以及教育培訓計畫的推動,進一步促進了該地區的成長。
預計亞太地區在預測期內將實現最高的複合年成長率,這主要得益於醫療基礎設施的不斷完善、醫療旅遊的蓬勃發展以及醫療行業對職業安全日益成長的關注。印度、日本和中國等國家正積極加大研發投入,以推出創新的安全針頭技術。此外,感染疾病的不斷蔓延也是該市場的關鍵特徵,促使醫療機構優先使用具有成本效益的安全針頭解決方案,從而推動了該地區市場的擴張。
According to Stratistics MRC, the Global Safety Needles Market is accounted for $2.4 billion in 2026 and is expected to reach $5.0 billion by 2034 growing at a CAGR of 9.3% during the forecast period. Medical needles with integrated safety features are known as safety needles. These devices are intended to shield patients and healthcare personnel against unwanted injuries caused by needle sticks, by lowering the chance of coming into contact with bloodborne pathogens, which improve patient safety in general. Furthermore, various types and sizes of safety needles are available to offer protection throughout a broad range of medical operations in clinics, hospitals, and other healthcare settings.
According to WHO, temporary boosts to government spending caused by the pandemic's aftermath amounted to a surge in global health expenditure close to US$9 trillion in 2020.
Patient empowerment
Patient empowerment, which involves patients who actively participate in their healthcare decisions, including the selection of safer medical devices like safety needles, is a major factor propelling the market for safety needles. They place a high value on comfort and safety, which makes them favor safety needles, which provide accuracy, less discomfort, and a lower chance of needlestick injuries. Furthermore, healthcare providers have been encouraged to embrace safety needle solutions that correspond with patient desires for safer and more effective healthcare experiences by the market's demand from informed and empowered patients.
High initial expenses
The initial cost of these goods might hinder healthcare providers from making an investment. Additionally, compared to regular needles, safety needles are typically more expensive due to their improved safety features, and the uptake may be hampered by the short-term financial restrictions, despite the fact that they reduce needlestick injuries and increase overall healthcare safety; however, compared to regular needles, the cost of fabrication and manufacturing goes up when these safety elements are added. Therefore, this could result in delayed market penetration and restricted access to safer needle options.
Technological advancements in needle safety
Tracking and compliance have increased due to innovative features such as integration with smart devices and electronic health records. Lowering the risk of injuries caused by needles, needle safety technology has increased patient and healthcare staff confidence. This has led to safer medical practices by providing practical solutions to reduce workplace hazards. In addition, increased knowledge of the risks associated with blood borne pathogens had improved safety features and accelerated by regulatory requirements which thereby boosting this market's growth.
Lack of awareness
Healthcare institutions and providers are frequently unaware of the availability and advantages of safety needles, which is a drawback in the safety needle market. As healthcare workers might continue to use normal needles without thinking about the risks involved, this could lead to a decrease in the use of safety needles. Additionally, another factor contributing is inadequate instruction and training regarding the benefits and application of safety needles, which significantly hampers market expansion.
Covid-19 Impact
The safety needle market has been affected as a result of the COVID-19 outbreak. There was a decrease in the necessity for safety needles as elective surgeries and non-emergency treatments were cancelled or postponed. Production and distribution of these devices were further hampered by disruptions in the worldwide supply chain and manufacturing procedures. Furthermore, Safety needles and other medical supplies received less attention and funding as healthcare institutions concentrated on controlling the infection and its after-effects which consequently impeding this market growth.
The IV catheter needles segment is expected to be the largest during the forecast period
The IV catheter needles segment is estimated to hold the largest share, due to the growing requirement for intravenous therapy and the emphasis on reducing needlestick injuries. Advancements such as needle locking mechanisms, user-friendly activation techniques, and improved designs for comfort are frequently applied to reduce the possibility of unintentional punctures during the insertion and removal of IV catheters. In addition, they frequently have retractable or shielding devices to protect patients and healthcare personnel, which is boosting this segment expansion.
The drug delivery segment is expected to have the highest CAGR during the forecast period
The drug delivery segment is anticipated to have highest CAGR during the forecast period. Injecting drugs is now safer and more convenient due to innovations in this market area, such as syringes with built-in safety features and needle-based drug delivery systems. These developments are especially important for diseases like diabetes and autoimmune disorders that call for the self-administration of medication. Furthermore, due to changing patient comfort and safety standards as well as changing healthcare needs, healthcare professionals and patients prioritize safer and more efficient means of medicine administration thereby driving this segment growth.
Europe commanded the largest market share during the extrapolated period, owing to regulations and incentives that have been implemented to improve worker safety, lower the number of needles tick injuries, and stop the spread of blood borne illnesses. This region is home to major key players such as Johnson & Johnson, Covidien, Becton, Dickinson & Company, and Smiths Medical, which are focusing on product innovation and technological advancements to meet evolving safety standards. In addition, the adoption of safety needle items offers funding, education, and training programs, which thereby boost this region's growth.
Asia Pacific is expected to witness highest CAGR over the projection period, owing to the expanding healthcare infrastructure, a surge in medical tourism, and an increasing focus on occupational safety in the healthcare sector. Countries including India, Japan, and China are strategically investing in research and development to introduce innovative safety needle technologies. Furthermore, the market is characterized by a growing prevalence of infectious diseases, spurring healthcare facilities to prioritize the use of safety devices with cost-effective safety needle solutions, which are therefore driving this region's expansion.
Key players in the market
Some of the key players in the Safety Needles Market include Boston Scientific Corporation, Medtronic, Plc., Smith Medical, Inc., Argon Medical devices, Inc., Terumo Corporation, Becton, Dickinson and Company, Abbott Laboratories, Novo Nordisk A/S, Nipro Medical Corporation, Eli Lily and Company and B. Braun Melsungen AG.
In October 2023, Boston Scientific Corporation announced that the U.S. Food and Drug Administration (FDA) has approved an expanded indication of the WaveWriter Alpha(TM) Spinal Cord Stimulator (SCS) Systems for the treatment of painful diabetic peripheral neuropathy (DPN), a complication of diabetes that can affect the lower extremities of the body.
In September 2023, Abbott and Bigfoot Biomedical announced a definitive agreement for Abbott to acquire Bigfoot, a leader in developing smart insulin management systems for people with diabetes.
In September 2023, Boston Scientific Corporation announced it has entered into a definitive agreement to acquire Relievant Medsystems, Inc., a privately held medical technology company that has developed and commercialized the Intracept(R) Intraosseous Nerve Ablation System to treat vertebrogenic pain, a form of chronic low back pain.
In April 2023, Abbott announced that it has completed the acquisition of Cardiovascular Systems, Inc., a medical device company with an innovative atherectomy system used in treating peripheral and coronary artery disease.